{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:42:49Z","timestamp":1772037769425,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.anai.2021.05.027","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T23:51:42Z","timestamp":1628725902000},"page":"530-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Treatment approaches for the patient with T2 low asthma"],"prefix":"10.1016","volume":"127","author":[{"given":"Tara F.","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.anai.2021.05.027_bib0001","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.anai.2021.05.027_bib0002","series-title":"2020 Focused Updates to the Asthma Management Guidelines: A Report From the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group","year":"2020"},{"issue":"5","key":"10.1016\/j.anai.2021.05.027_bib0003","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.anai.2021.05.027_bib0004","series-title":"Global strategy for asthma management and prevention","year":"2019"},{"issue":"5","key":"10.1016\/j.anai.2021.05.027_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/ajcp\/75.5.693","article-title":"Within-day physiologic variation of leukocyte types in healthy subjects as assayed by two automated leukocyte differential analyzers","volume":"75","author":"Winkel","year":"1981","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.anai.2021.05.027_bib0006","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jaci.2012.04.046","article-title":"Immune response modifiers in the treatment of asthma: a PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology","volume":"130","author":"Ballow","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.05.027_bib0007","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2021.05.027_bib0008","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaci.2013.07.036","article-title":"Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma","volume":"133","author":"Peters","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2021.05.027_bib0009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaci.2010.10.024","article-title":"Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples","volume":"127","author":"Baines","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.05.027_bib0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/rccm.201109-1640OC","article-title":"A large subgroup of mild-to-moderate asthma is persistently noneosinophilic","volume":"185","author":"McGrath","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.anai.2021.05.027_bib0011","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","article-title":"Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis","volume":"133","author":"Moore","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2021.05.027_bib0012","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaci.2019.08.031","article-title":"Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma","volume":"145","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0013","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/thoraxjnl-2020-215168","article-title":"Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era","volume":"76","author":"Jackson","year":"2021","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.anai.2021.05.027_bib0014","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ni1467","article-title":"Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells","volume":"8","author":"Acosta-Rodriguez","year":"2007","journal-title":"Nat Immunol"},{"issue":"7198","key":"10.1016\/j.anai.2021.05.027_bib0015","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/resp.12730","article-title":"Neutrophil extracellular traps are associated with inflammation in chronic airway disease","volume":"21","author":"Wright","year":"2016","journal-title":"Respirology"},{"issue":"5","key":"10.1016\/j.anai.2021.05.027_bib0017","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jaci.2014.05.038","article-title":"Increased frequency of dual-positive TH2\/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma","volume":"134","author":"Irvin","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.05.027_bib0018","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jaci.2016.08.032","article-title":"Mechanism of T H 2\/T H 17-predominant and neutrophilic T H 2\/T H 17-low subtypes of asthma","volume":"139","author":"Liu","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"301","key":"10.1016\/j.anai.2021.05.027_bib0019","doi-asserted-by":"crossref","first-page":"301ra129","DOI":"10.1126\/scitranslmed.aab3142","article-title":"TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma","volume":"7","author":"Choy","year":"2015","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1016\/j.anai.2021.05.027_bib0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.anai.2021.05.027_bib0021","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaci.2019.06.011","article-title":"Thymic stromal lymphopoietin epigenetically upregulates Fc receptor \u03b3 subunit-related receptors on antigen-presenting cells and induces T H 2\/T H 17 polarization through dectin-2","volume":"144","author":"Liang","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.anai.2021.05.027_bib0022","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.4049\/jimmunol.0902515","article-title":"Thymic stromal lymphopoietin receptor-mediated IL-6 and CC\/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1\/2, p38, and JNK) and STAT3 pathways","volume":"184","author":"Shan","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.anai.2021.05.027_bib0023","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/srep02301","article-title":"Thymic stromal lymphopoietin induces migration in human airway smooth muscle cells","volume":"3","author":"Redhu","year":"2013","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.anai.2021.05.027_bib0024","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/all.14573","article-title":"Type 2-low asthma phenotypes by integration of sputum transcriptomics and serum proteomics","volume":"76","author":"Zounemat Kermani","year":"2021","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.anai.2021.05.027_bib0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"issue":"16","key":"10.1016\/j.anai.2021.05.027_bib0026","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.2015.13277","article-title":"Anticholinergic vs long-acting \u03b2-agonist in combination with inhaled corticosteroids in Black adults with asthma: the BELT Randomized Clinical Trial","volume":"314","author":"Wechsler","year":"2015","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.anai.2021.05.027_bib0027","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1814917","article-title":"Mometasone or tiotropium in mild asthma with a low sputum eosinophil level","volume":"380","author":"Lazarus","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0028","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaip.2017.08.037","article-title":"Tiotropium Respimat add-on is efficacious in symptomatic asthma, independent of T2 phenotype","volume":"6","author":"Casale","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0029","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.iac.2016.03.010","article-title":"Chronic infection and severe asthma","volume":"36","author":"Carr","year":"2016","journal-title":"Immunol Allergy Clin North Am"},{"issue":"10095","key":"10.1016\/j.anai.2021.05.027_bib0030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","article-title":"Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Gibson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2021.05.027_bib0031","doi-asserted-by":"crossref","unstructured":"Shukla SD, Taylor SL, Gibson PG, et\u00a0al. Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: an AMAZES substudy. Thorax. doi:10.1136\/thoraxjnl-2020-216331.","DOI":"10.1136\/thoraxjnl-2020-216331"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0032","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201809-1739OC","article-title":"Long-term azithromycin reduces Haemophilus influenzae and increases antibiotic resistance in severe asthma","volume":"200","author":"Taylor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.anai.2021.05.027_bib0033","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1164\/rccm.201311-2011LE","article-title":"Obese individuals with asthma preferentially have a high IL-5\/IL-17A\/IL-25 sputum inflammatory pattern","volume":"189","author":"Marijsse","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0034","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ppul.24600","article-title":"Pediatric obesity-related asthma: a prototype of pediatric severe non-T2 asthma","volume":"55","author":"Rastogi","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.anai.2021.05.027_bib0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1183\/13993003.00246-2016","article-title":"Insulin resistance modifies the association between obesity and current asthma in adults","volume":"48","author":"Cardet","year":"2016","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.anai.2021.05.027_bib0036","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1164\/rccm.201401-0097OC","article-title":"Pathway from central obesity to childhood asthma. Physical fitness and sedentary time are leading factors","volume":"189","author":"Chen","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.anai.2021.05.027_bib0037","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1378\/chest.14-2689","article-title":"Obesity and bronchodilator response in Black and Hispanic children and adolescents with asthma","volume":"147","author":"McGarry","year":"2015","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.anai.2021.05.027_bib0038","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1164\/rccm.201401-0178OC","article-title":"The nonallergic asthma of obesity. A matter of distal lung compliance","volume":"189","author":"Al-Alwan","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.anai.2021.05.027_bib0039","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s41366-021-00788-4","article-title":"Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database","volume":"45","author":"Haase","year":"2021","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"10.1016\/j.anai.2021.05.027_bib0040","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaci.2018.02.004","article-title":"Obesity and asthma","volume":"141","author":"Peters","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0041","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaip.2017.10.026","article-title":"Impact of lifestyle interventions targeting healthy diet, physical activity, and weight loss on asthma in adults: what is the evidence?","volume":"6","author":"Nyenhuis","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0042","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1183\/09031936.00073312","article-title":"Smoking and asthma: dangerous liaisons","volume":"41","author":"Polosa","year":"2013","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.anai.2021.05.027_bib0043","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1378\/chest.05-3084","article-title":"Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study","volume":"132","author":"Osborne","year":"2007","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.anai.2021.05.027_bib0044","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.200304-503OC","article-title":"Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma","volume":"168","author":"Chaudhuri","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.anai.2021.05.027_bib0045","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.200511-1746OC","article-title":"Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma","volume":"175","author":"Lazarus","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.anai.2021.05.027_bib0046","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1164\/rccm.200510-1589OC","article-title":"Effects of smoking cessation on lung function and airway inflammation in smokers with asthma","volume":"174","author":"Chaudhuri","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.anai.2021.05.027_bib0047","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jaci.2008.06.029","article-title":"Reduction in asthma-related emergency department visits after implementation of a smoke-free law","volume":"122","author":"Rayens","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"147","key":"10.1016\/j.anai.2021.05.027_bib0048","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0119-2017","article-title":"Immunological and toxicological risk assessment of e-cigarettes","volume":"27","author":"Kaur","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"5","key":"10.1016\/j.anai.2021.05.027_bib0049","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.chest.2019.12.042","article-title":"The evolving landscape of e-cigarettes: a systematic review of recent evidence","volume":"157","author":"Bozier","year":"2020","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.anai.2021.05.027_bib0050","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.anai.2021.05.027_bib0051","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1164\/rccm.201212-2318OC","article-title":"Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma","volume":"188","author":"Busse","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.anai.2021.05.027_bib0052","doi-asserted-by":"crossref","first-page":"e1044","DOI":"10.1002\/cti2.1044","article-title":"Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics","volume":"8","author":"Revez","year":"2019","journal-title":"Clin Transl Immunology"},{"issue":"2","key":"10.1016\/j.anai.2021.05.027_bib0053","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1164\/rccm.201312-2235OC","article-title":"The effect of inhaled IFN-\u03b2 on worsening of asthma symptoms caused by viral infections. A randomized trial","volume":"190","author":"Djukanovic","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.anai.2021.05.027_bib0054","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaci.2021.01.037","article-title":"PrecISE: precision medicine in severe asthma: an adaptive platform trial with biomarker ascertainment","volume":"147","author":"Israel","year":"2021","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621004178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621004178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:26:35Z","timestamp":1761053195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621004178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1081120621004178"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.05.027","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment approaches for the patient with T2 low asthma","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}